ATE202599T1 - Mit isoliertem empfindlichem x-syndrom verbundene dns-sequenzen - Google Patents

Mit isoliertem empfindlichem x-syndrom verbundene dns-sequenzen

Info

Publication number
ATE202599T1
ATE202599T1 AT92904375T AT92904375T ATE202599T1 AT E202599 T1 ATE202599 T1 AT E202599T1 AT 92904375 T AT92904375 T AT 92904375T AT 92904375 T AT92904375 T AT 92904375T AT E202599 T1 ATE202599 T1 AT E202599T1
Authority
AT
Austria
Prior art keywords
syndrome
dna sequences
sequences associated
isolated
sensitive
Prior art date
Application number
AT92904375T
Other languages
English (en)
Inventor
Grant R Sutherland
Robert I Richards
David Schlessinger
Ramaiah Nagaraja
Original Assignee
Univ Washington
Adelaide Medical Ct For Women
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27417620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE202599(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Washington, Adelaide Medical Ct For Women filed Critical Univ Washington
Application granted granted Critical
Publication of ATE202599T1 publication Critical patent/ATE202599T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Error Detection And Correction (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT92904375T 1991-01-04 1992-01-03 Mit isoliertem empfindlichem x-syndrom verbundene dns-sequenzen ATE202599T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63851891A 1991-01-04 1991-01-04
US67223291A 1991-03-20 1991-03-20
US80265091A 1991-12-06 1991-12-06
PCT/US1992/000020 WO1992012262A1 (en) 1991-01-04 1992-01-03 Dna sequences related to isolated fragile x syndrome

Publications (1)

Publication Number Publication Date
ATE202599T1 true ATE202599T1 (de) 2001-07-15

Family

ID=27417620

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92904375T ATE202599T1 (de) 1991-01-04 1992-01-03 Mit isoliertem empfindlichem x-syndrom verbundene dns-sequenzen

Country Status (11)

Country Link
US (2) US6197500B1 (de)
EP (1) EP0724646B1 (de)
JP (1) JPH06504443A (de)
AT (1) ATE202599T1 (de)
AU (1) AU668857B2 (de)
CA (1) CA2094938A1 (de)
DE (1) DE69231903T2 (de)
DK (1) DK0724646T3 (de)
ES (1) ES2159279T3 (de)
GR (1) GR3036691T3 (de)
WO (1) WO1992012262A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672618B1 (fr) * 1991-02-13 1994-12-02 Centre Nat Rech Scient Fragment d'acide nucleique de la region du chromosome x implique dans le syndrome x fragile, sonde nucleotidique et procede pour le diagnostic du retard mental avec x fragile.
US5861504A (en) * 1991-05-29 1999-01-19 The United States Of America As Represented By The Department Of Health And Human Services Eleven highly informative microsatelite repeat polymorphic DNA markers
US5378602A (en) * 1991-05-29 1995-01-03 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Highly informative microsatellite repeat polymorphic DNA markers twenty-[seven]six
GB9311113D0 (en) * 1993-05-28 1993-07-14 Medical Res Council Probes
US5834183A (en) * 1993-06-29 1998-11-10 Regents Of The University Of Minnesota Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis
US5741645A (en) * 1993-06-29 1998-04-21 Regents Of The University Of Minnesota Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis
GB9326052D0 (en) * 1993-12-21 1994-02-23 Zeneca Ltd Sequences
US5876949A (en) * 1995-05-31 1999-03-02 The Trustees Of The University Of Pennsylvania Antibodies specific for fragile X related proteins and method of using the same
GB9519299D0 (en) 1995-09-21 1995-11-22 Farrar Gwyneth J Genetic strategy
GB9604449D0 (en) * 1996-03-01 1996-05-01 Farrar Gwyneth J Genetic strategy ii
GB9606961D0 (en) 1996-04-02 1996-06-05 Farrar Gwyneth J Genetic strategy III
US8551970B2 (en) 1996-04-02 2013-10-08 Optigen Patents Limited Genetic suppression and replacement
WO2000024938A2 (en) * 1998-10-27 2000-05-04 The Johns Hopkins University CCG REPEATS IN cDNAs FROM HUMAN BRAIN
AUPR909501A0 (en) 2001-11-26 2001-12-20 Bionomics Limited A novel homeobox gene
US7115374B2 (en) * 2002-10-16 2006-10-03 Gen-Probe Incorporated Compositions and methods for detecting West Nile virus
US7927840B2 (en) * 2006-09-11 2011-04-19 Gen Probe Incorporated Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
US20050191636A1 (en) * 2004-03-01 2005-09-01 Biocept, Inc. Detection of STRP, such as fragile X syndrome
AU2007237444B2 (en) * 2006-04-17 2013-05-23 Epigenomics Ag Methods and nucleic acids for the detection of colorectal cell proliferative disorders
EP2633073B1 (de) * 2010-10-29 2017-04-26 Asuragen, Inc. Mpcr verfahren zur analyse von wiederholungssequenzen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2578847A1 (fr) 1985-03-13 1986-09-19 Centre Nat Rech Scient Sonde adn destinee au diagnostic antenatal de certaines anomalies chromosomiques
GB8825530D0 (en) * 1988-11-01 1988-12-07 Medical Res Council Probe
GB8928029D0 (en) * 1989-12-12 1990-02-14 Medical Res Council Probe
WO1992014840A1 (fr) 1991-02-13 1992-09-03 Institut National De La Sante Et De La Recherche Medicale Fragment d'acide nucleique de la region du chromosome x implique dans le syndrome x fragile, sonde nucleotidique et procede pour le diagnostic du retard mental avec x fragile
US6180337B1 (en) * 1991-05-24 2001-01-30 Baylor College Of Medicine Diagnosis of the fragile X syndrome

Also Published As

Publication number Publication date
DE69231903D1 (de) 2001-08-02
EP0724646A4 (de) 1995-06-09
EP0724646A1 (de) 1996-08-07
GR3036691T3 (en) 2001-12-31
US6242576B1 (en) 2001-06-05
AU668857B2 (en) 1996-05-23
WO1992012262A1 (en) 1992-07-23
EP0724646B1 (de) 2001-06-27
AU1221192A (en) 1992-08-17
DK0724646T3 (da) 2001-09-03
US6197500B1 (en) 2001-03-06
JPH06504443A (ja) 1994-05-26
DE69231903T2 (de) 2001-10-31
ES2159279T3 (es) 2001-10-01
CA2094938A1 (en) 1992-07-05

Similar Documents

Publication Publication Date Title
ATE202599T1 (de) Mit isoliertem empfindlichem x-syndrom verbundene dns-sequenzen
NO873298L (no) Oralt terapeutisk system med systematisk virkning.
DE68918961D1 (de) Verstellbarer Rollstuhl.
DE68921273D1 (de) System zum kontinuierlichen Behandeln von Halbleitersubstraten.
NO911789D0 (no) Rullestol med et seks-hjuls understell.
FI895769A7 (fi) Nahan käsittely selektoiduilla amfifiilisillä kopolymeereillä
NL300066I2 (nl) Behandeling van zwaarlijvigheid.
DE69113205D1 (de) Transdermales therapeutisches System.
FI881177A0 (fi) Anordning foer positionering av en patient i en medicinsk panoramaroentgenfotograferingsanordning.
DE68919870D1 (de) Integrierte Dünnschichtmembrane.
FI874671A0 (fi) Anordning foer foerhindrande av laeckage i tryckledningar.
FI875098A7 (fi) Transdermaalinen terapeuttinen systeemi.
FI884048A7 (fi) Foerfarande foer bestaemning av halten av en gaskomponent i en patients andningsluft.
DE69201660D1 (de) Verwendung von Acetyl L-Carnitin zur therapeutischen Behandlung von Coma.
NO891560D0 (no) Underlag saerlig for bevegelseshemmede personer.
DE68900210D1 (de) Pyranobenzoxadiazolderivate, herstellung, verwendung und diese enthaltende zubereitungen.
ATE87333T1 (de) Rezeptor der kleinen rhinovirus rezeptor gruppe.
DE69734461D1 (de) Verwendung von mycobacterium vaccae zur therapie des chronischen müdigkeitssyndrom
FI892228L (fi) I vattenhaltig alkaliloesning framkallningsbara, med uv-ljus haerdbara uretanakrylatfoereningar och -kompositioner, anvaendbara foer framstaellning av fasta, loesningsmedelfria, flytande loedmaskeringsbelaeggningar.
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DE68913090D1 (de) Modifizierter menschlicher PSTI.
NO984651L (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
NO880074L (no) Hoeyderegulerbar rullestol.
NO894187D0 (no) Terapeutiske forbindelser.
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee